Duke-NUS receives UK funding for cardiovascular health study

Cardiovascular diseases (CVD) such as strokes and heart attacks have become the leading causes of death globally and in South Asian countries. High blood pressure or hypertension confers the highest attributable risk of CVD. About 1 in 4 adults suffer from hypertension in South Asia. 


In recognition of the growing burden of CVD morbidity and mortality from hypertension,   Professor Tazeen Jafar and team at Duke-NUS Singapore have been funded by the UK-based Joint Global Health Trials Scheme of the Medical Research Council (MRC), the Wellcome Trust, and the Department for International Development (DFID), to lead the design of Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka (COBRA-BPS) feasibility study. 


This study will evaluate evidence-based potentially sustainable health systems interventions to control blood pressure and decrease the risk of developing cardiovascular diseases among hypertensive patients in the primary care settings in rural Bangladesh, Pakistan, and Sri Lanka. 


The partnering centers include the International Centre for Diarrhoeal Disease Research, Bangladesh, Aga Khan University (Pakistan), University of Kelaniya (Sri Lanka) and the London School of Hygiene and Tropical Medicine (United Kingdom). 


Duke-NUS is the coordinating center and held the first Study Group meeting at its campus in Singapore on April 24th and 25th with the international delegates to discuss implementation strategies. 


For more information on the study, contact: 
Professor Tazeen H. Jafar
Program in Health Services & Systems Research  
Duke-NUS Graduate Medical School Singapore  
Tel: (65) 66012582 
Email: tazeen.jafar@duke-nus.edu.sg  
Web: www.duke-nus.edu.sg